DR. STEVEN A. HUTCHINSON, MD

Plain English
This study focused on improving the investigation of acid attacks, known as vitriolage, by analyzing the fabrics of clothing exposed to different types of commercial acids like sulfuric, nitric, and hydrochloric acid. Researchers discovered that clothing made of wool could be accurately classified regarding which acid it contacted, achieving 100% accuracy, while cotton and polyester showed lower accuracy rates between 77.5% and 85%. This method can help law enforcement narrow down suspects based on the type of acid used and the type of clothing they were wearing at the time of the attack. Who this helps: This helps victims of acid attacks and the investigators working on their cases.

Plain English
The study focused on COVID-19 vaccination rates among people in prison and those released from prison in Scotland, particularly looking at how their vaccination rates compared with the general population and their risk of severe COVID-19 outcomes. It found that about 73.4% of incarcerated individuals received their first vaccine dose, which is similar to the general population (72.9%). However, recently released individuals were less likely to get vaccinated and were at higher risk of severe illness from COVID-19—over three times more likely than those outside of prison. Who this helps: This helps patients in prison and those recently released by ensuring they have better access to vaccinations to protect their health.

Plain English
This study evaluated how well a type of gelling fiber dressing, made from sodium carboxymethylcellulose, conforms to different wound shapes when it gets wet. Researchers developed a new testing method that showed this dressing maintains a moist environment for healing and limits gaps that could lead to infection. They found that their approach consistently measured how well the dressing fit, with less than 10% variation across different testers. Who this helps: This helps patients with wounds by ensuring they receive better, more effective dressings for healing.

Plain English
This study looked at the prescription treatment needs of people in the U.S. who experience migraines. It found that 77.1% of the 59,001 participants needed help with their migraine treatment, with 39.4% having urgent needs for acute treatment and 34.9% needing both acute and preventive treatments. This matters because many people with migraines are not getting the effective treatments they need, which can lead to reduced quality of life and increased stigma around their condition. Who this helps: This helps patients suffering from migraines who need better treatment options.

Plain English
This study looked at how primary lateral sclerosis (PLS), a rare nerve disease causing muscle stiffness and movement problems, affects different areas of the brain. Researchers found that PLS damages not only the motor areas but also other parts of the brain, particularly those with high energy use, such as the cerebellum and certain frontal regions. They identified specific brain regions where changes in structure were closely linked to energy activity, revealing that the areas most affected by PLS are crucial for its main symptoms. Who this helps: This information benefits patients with PLS and their doctors by improving understanding of the disease's impact on the brain.

Plain English
Researchers studied the effectiveness of a self-mixed morphine gel (0.125%) to help manage pain in 13 cancer patients with painful skin lesions. They found that 91% of the patients found it easy to mix and helpful, with their pain scores dropping by 61.8%, and the amount of oral morphine they needed also significantly reduced. This matters because it offers patients a safer and more affordable way to manage pain from cancer lesions without heavy side effects. Who this helps: This helps cancer patients experiencing localized pain.

Plain English
This study looked at how different factors, both changeable and unchangeable, influence thinking skills in middle-aged people who may be at risk for Alzheimer's disease. Researchers found that engaging in stimulating activities had the strongest positive effect on cognitive abilities, while symptoms of depression and past brain injuries were the biggest negative influences. These findings underscore the importance of taking proactive steps in mid-life to reduce risks and enhance mental resilience to potentially prevent dementia later on. Who this helps: This helps patients and their families, healthcare providers, and caregivers.

Plain English
This study looked at the impact of a seven-year program in Scotland that provides a preventive treatment for HIV, called PrEP, for gay and bisexual men. The results showed that the number of new HIV cases plummeted, dropping from 4.46 cases per 1,000 men to just 1.66 cases per 1,000 during the initial rollout of PrEP, with only 4 new cases among those currently taking PrEP compared to 60 in those who had never taken it. This matters because maintaining access and encouraging continued use of PrEP can help keep HIV rates low. Who this helps: This helps patients at risk of HIV, particularly gay and bisexual men.

Plain English
Researchers studied how well a computer model could predict the likelihood of pancreatic cancer coming back after surgery. They trained this model using images from tissue samples taken from 257 patients, discovering that those with high-risk characteristics had a 49% higher chance of dying and a 41% higher chance of recurrence compared to those classified as low-risk. This is important because better risk predictions can help doctors make more informed treatment decisions for their patients. Who this helps: This helps patients with pancreatic cancer and their doctors.

Plain English
This study focuses on how to help cancer patients deal with mental and emotional distress. It outlines guidelines for healthcare teams to identify when patients need extra support and offers strategies for addressing their psychosocial issues. By following these recommendations, doctors and support staff can provide better care to those who are facing significant distress related to their cancer treatment. Who this helps: Patients undergoing cancer treatment and their support teams.

Plain English
This study focused on creating a new tool using Artificial Intelligence to help doctors choose the best chemotherapy for patients with advanced pancreatic cancer. The researchers found that their tool could accurately predict whether patients would do better on one of two chemotherapy options, gemcitabine or fluoropyrimidine. For example, patients who were advised to take fluoropyrimidine experienced longer times before needing additional treatment (8.6 months versus 7.5 months) and longer overall survival (14.4 months versus 11.7 months) compared to those on gemcitabine. Who this helps: This benefits patients with advanced pancreatic cancer by providing better chemotherapy treatment choices.

Plain English
This study examined how repeated head injuries in retired athletes can affect the blood-brain barrier (BBB) and lead to cognitive decline. Researchers found that 47 athletes exhibited BBB disruptions even years after retirement, and those with severe BBB issues had worse cognitive decline—17 specifically suffered more than others. This is important because it shows that repetitive head trauma can cause long-lasting cognitive problems and that inflammation in the body may play a role in this decline. Who this helps: This helps retired athletes and their healthcare providers in understanding the impact of repetitive head injuries on brain health.

Plain English
This study looked at how increasing Hepatitis C (HCV) treatment with direct-acting antiviral agents from 2015 to 2020 affected the number of HCV cases among people who inject drugs. It found that in some areas of the UK, like Tayside, Glasgow, and South Yorkshire, the number of HCV cases dropped significantly—by as much as 65% compared to 2015 levels. This matters because it shows that making more treatment available can effectively lower HCV rates in a high-risk group. Who this helps: This helps patients who inject drugs, as well as healthcare providers working to reduce HCV.

Plain English
This study looked at why many people with migraines are hesitant to seek medical care, using responses from over 58,000 migraine sufferers in the U.S. It found that 45.1% of participants had ever hesitated to get help, with key reasons including wanting to handle their migraines on their own (44.2%) and doubts about whether their condition would be taken seriously (33.8%). These findings highlight that social factors, like stigma and the desire to hide their condition, are significant barriers to receiving proper migraine care. Who this helps: Patients with migraines and healthcare providers.

Plain English
This study looked at the safety of a medication called rimegepant in adults who suffer from migraines and also have anxiety or depression, or who are taking antidepressants. Out of 1,800 participants, about 23% reported anxiety, 24% reported depression, and around 10% were using selective serotonin reuptake inhibitors (SSRIs) or other antidepressants. The findings showed that rimegepant was generally safe and well-tolerated across different groups, with similar rates of side effects observed regardless of anxiety or antidepressant use. Who this helps: This helps patients with migraines who also struggle with anxiety or depression.

Plain English
This study looked at death rates among people in Scotland who inject drugs and also have HIV over a 20-year period. It found that 20.5% of the 430 individuals studied died, with drug-related deaths making up almost half of these deaths. Notably, the risk of dying was significantly higher for people diagnosed more recently, with a death rate of 37.62 per 1000 people in the first five years after diagnosis, indicating a growing crisis that needs urgent attention. Who this helps: This research benefits patients living with HIV who inject drugs and the healthcare providers working with them.

Plain English
Researchers studied the feelings of stigma that people with migraines experience. They created a new questionnaire called the Migraine-Related Stigma (MiRS) questionnaire, testing it on over 61,000 adults with migraines. The findings showed that there are two main types of this stigma: one related to perceived personal gain from having migraines and another about minimizing the burden that migraines cause. Who this helps: This benefits individuals living with migraines by helping to better understand their experiences and inform efforts to reduce stigma.

Plain English
This research focused on pseudobulbar affect (PBA), a condition that causes uncontrollable laughing or crying in patients with certain neurological diseases, specifically Primary Lateral Sclerosis (PLS). The study found that 85% of PLS patients experienced poorly controlled laughing, while 69% had crying episodes, and significant symptoms were linked to motor issues like trouble swallowing (with a likelihood of 14 times higher) and an abnormal jaw reflex (almost 20 times higher). Understanding and recognizing PBA is important because it can lead to social isolation and lower quality of life, yet many patients were unaware that it was common in their condition. Who this helps: This helps patients with neurological conditions and their caregivers.

Plain English
This study looked at how people without migraines feel about those who do have them, and it found that nearly 70% of respondents showed at least one negative attitude toward people with migraines. Those who knew someone with migraines or had experienced migraines themselves were more likely to hold these negative views. This is important because it highlights a significant stigma that may prevent people with migraines from getting the support and care they need. Who this helps: This research benefits patients with migraines by highlighting stigma that needs to be addressed to improve their care and support.

Plain English
This study investigated how the cerebellum, a part of the brain often overlooked in frontotemporal dementia (FTD) and conditions like amyotrophic lateral sclerosis (ALS), affects patient symptoms. Researchers found that people with FTD showed significant issues in brain connections involving the cerebellum, with different patterns of brain atrophy; for instance, certain ALS-FTD patients experienced both anterior and posterior cerebellar volume loss, while others faced disconnections in brain networks. Understanding these cerebellar issues is crucial for better diagnosis and treatment of FTD and ALS-FTD, as it highlights the importance of the cerebellum in these conditions. Who this helps: This benefits patients with frontotemporal dementia and their doctors by improving understanding of their disease.

Plain English
Researchers focused on improving a type of protein detection tool called quenchbodies, which light up more brightly when they bind to specific proteins. They enhanced these tools using nanobodies, achieving a significant increase in brightness, from a previous maximum of 1.4 times to between 1.5 and 2.4 times for detecting the inflammatory protein interleukin-6 (IL-6) at very low levels (1-2 nanomolar). This improvement helps create more effective biosensors for medical testing and research, making it easier to identify proteins linked to diseases. Who this helps: This benefits patients, doctors, and researchers looking for better diagnostic tools.

Plain English
This study looked at the genetic characteristics of 268 patients with advanced pancreatic cancer while they were part of a trial comparing two treatments: modified FOLFIRINOX and Gemcitabine-nab-paclitaxel. The results showed that the average survival time for patients on modified FOLFIRINOX was 10.6 months, compared to 8.4 months for those on Gemcitabine-nab-paclitaxel. The research found that certain genetic patterns, particularly in "basal-like pancreatic cancer," are linked to worse outcomes and that some patients with this type of cancer showed signs of inflammation that could affect their prognosis. Who this helps: This helps patients with advanced pancreatic cancer by identifying which subgroups may respond better to specific treatments.

Plain English
This study looked at the effects of opioid-agonist treatment (OAT) during the COVID-19 pandemic in Scotland to see how it influenced drug-related deaths. Researchers found that, from 2020 to 2022, 34,241 people received OAT and there were 1,825 drug-related deaths, which was stable compared to the years before the pandemic. Notably, OAT significantly lowered the risk of drug-related death, showing that keeping people on treatment is crucial even during emergencies. Who this helps: Patients struggling with opioid addiction.

Plain English
This research studied a new way to evaluate how people use power wheelchairs, focusing on safety while driving. The team developed a robotic wheelchair system called the Robotic Individualized Driving Evaluation (RIDE), which provided personalized assessments based on individual driving behaviors and the unique challenges they face. The findings showed that this new method identified different levels of risk for different users and driving tasks, which is a significant improvement over traditional assessments that don’t account for individual differences. Who this helps: This benefits patients who use power wheelchairs by ensuring safer driving assessments tailored to their needs.

Plain English
This study looked at the long-term effects of hepatitis C treatment on people who inject drugs. Researchers interviewed 30 individuals, finding three main outcomes: some experienced a positive transformation in their lives with improved health and reduced drug use, others felt isolated and struggled with their new reality, while a few only changed their approach to health check-ups but did not see much else change. These findings are important because they highlight both the potential benefits and challenges that people face after treatment, indicating a need for ongoing support. Who this helps: This helps patients recovering from hepatitis C and healthcare providers who support them.

Plain English
This study focused on improving how drug-related infectious diseases, like HIV and hepatitis, are monitored in people who inject drugs in Europe. The researchers updated guidelines to make sure that key information, like the number of people infected and their access to treatment, is consistently collected. This matters because better tracking can help health organizations address these diseases more effectively and work towards ending related epidemics. Who this helps: Patients, specifically those who inject drugs and are at risk of these infections.

Plain English
This study explored whether using large amounts of data to teach robots how to perform tasks is effective. The researchers debated whether this method would meaningfully advance the field of robotics. Their discussions highlight the potential impact of data on robot training and automation in the future. Who this helps: This helps researchers and engineers working in robotics and automation.

Plain English
This study examined opioid use among people with migraines, revealing that 21.5% of the participants, which included over 61,000 individuals, were using opioids to treat their headaches. Most of these opioid users were women, and they tended to have higher rates of tobacco use, additional health issues, and greater disability from their migraines compared to those who didn't use opioids. The findings show that those who use opioids for migraines are more likely to also be using other treatments and to seek emergency care, highlighting the need to find ways to reduce opioid dependence in migraine treatment. Who this helps: This benefits migraine patients by promoting better treatment approaches and reducing reliance on opioids.

Plain English
This study developed a new tool called the Efficient Multifunction fMRI localizer (EMFL), which allows researchers to quickly identify 14 important areas in the brain related to vision, hearing, and cognitive tasks in just 14 minutes of scanning. The EMFL works just as well as traditional methods but takes only a quarter of the time. This is important because faster identification of brain regions can help advance research on how the brain works and improve our understanding of mental processes. Who this helps: This benefits researchers and scientists studying brain functions.

Plain English
This research paper looks at how migraines affect women at different life stages, focusing on how estrogen levels and a substance called calcitonin gene-related peptide (CGRP) play a role. It found that women experience more severe migraines when their estrogen levels drop or fluctuate, while stable estrogen can sometimes provide relief. Understanding these connections is important because it can lead to better treatment options for women suffering from migraines throughout their lives. Who this helps: This helps women experiencing migraines, particularly during hormonal changes like menstruation and menopause.

Plain English
This study looked at how certain genes in African trypanosomes, which are parasites that cause sleeping sickness, regulate their surface proteins to avoid detection by the host's immune system. Researchers discovered that a specific gene, called VSG, produces far more RNA than other similar genes, with the active one making 10,000 times more. When they blocked the protein production from this gene or reduced its RNA, it didn't stop the exclusion of other similar genes, but other changes occurred that affected the cell's structure. Who this helps: This research benefits scientists studying parasite behavior and may inform future treatments for infections like sleeping sickness.

Plain English
This research looked at how to track progress in eliminating hepatitis C among people who inject drugs in the UK. The goal is to show that new infections are at or below 2 for every 100 people each year. The study found that various methods, including public health surveys and advanced mathematical models, can help measure progress. For example, different models can estimate infection rates based on existing data, showing trends in chronic infections and treatment rates, which are crucial for understanding if elimination goals are met. Who this helps: This benefits public health officials and healthcare providers working to reduce hepatitis C infections in high-risk populations.

Plain English
This study examined how the density of mitochondria (the energy-producing parts of cells) relates to brain shrinkage in different types of frontotemporal lobar degeneration (FTLD), a group of disorders that impact behavior and language. Researchers found that there are weak correlations between brain atrophy and mitochondrial density in various FTD types, with correlation values ranging from 0.182 to 0.292, but stronger associations in specific brain regions crucial to each disorder’s symptoms, with values above 0.65. This is important because it suggests that mitochondrial health could play a role in the progression of these brain diseases, which may help inform future treatments. Who this helps: This research benefits patients with frontotemporal lobar degeneration and their doctors.

Plain English
This study looked at a protein called GATA6 in patients who had surgery for pancreatic cancer to find out if it could help predict how long they might live after treatment. They found that patients with low GATA6 levels lived about 24.3 months on average, while those with high levels lived about 35.2 months. This is important because it could help doctors better assess patient outcomes and tailor follow-up treatments. Who this helps: Patients with pancreatic cancer and their doctors.

Plain English
This study looked at how stigma around migraines affects people’s lives. Researchers found that 31.7% of those with migraines often felt stigmatized, and this stigma led to more disability and a lower quality of life. For those who felt the most stigma, their disability was more than twice as severe compared to those who felt no stigma at all. Who this helps: Patients who suffer from migraines and their healthcare providers.

Plain English
This study looked at how many people receiving treatment for opioid dependence in Scotland got vaccinated against COVID-19 and how this affected their chances of serious illness from the virus. It found that only 31% of these individuals received three vaccine doses, compared to 57% of the general population. People on opioid treatment were at a higher risk of severe illness, especially during the fourth wave of the pandemic, where those who had been treated recently were 3.78 times more likely to get severely ill compared to those who were not currently on treatment. Who this helps: This research benefits patients with opioid dependence by highlighting their increased risks and the importance of vaccination.

Plain English
This study looked at why some people with migraines seek medical help while others do not. Researchers found that out of 61,826 people with migraines, 31,529 (51%) had seen a healthcare professional for their headaches in the past year. Those who sought care reported more severe headache-related issues, with 52.8% experiencing significant pain between migraine attacks and 36.7% having a high level of disability from migraines. Who this helps: This research benefits patients with migraines by identifying key factors that may motivate them to seek medical care.

Plain English
This study looked at the effects of an inter-professional clinic on patients with pancreatic cancer, specifically how it affected their survival and overall care. Researchers found that patients treated after the clinic was established lived longer (an average of 0.84 times the risk of dying, showing a significant improvement) and had their first appointments much faster, with the wait time dropping from 13.4 days to 8.8 days. Overall, these patients reported better well-being and received more support from health professionals. **Who this helps:** This benefits patients with pancreatic cancer and their families by improving their care experience and outcomes.

Plain English
This study looks at how effective a treatment called Behavioral Activation (BA) can be for people in custody who are struggling with depression. Researchers will have 60 participants receive BA along with regular treatment for six weeks and then check their mental health and quality of life over time. The goal is to see if this method can be easily and acceptably used in prisons, which is important because it could lead to better mental health support for inmates, ultimately improving their lives while in custody and after release. Who this helps: This helps inmates dealing with depression, as well as healthcare providers in prisons.

Plain English
This study looked at people in Scotland who were receiving treatment for opioid dependence and found that many were also prescribed gabapentinoids and Z-drugs, which are types of sedative medications. Out of over 46,000 participants, 25% were given gabapentinoids and 34% received Z-drugs, and taking these together was linked to a higher risk of drug-related death. Specifically, using gabapentinoids increased the risk by more than twice, while Z-drug use raised the risk by about 39%. Who this helps: This research helps patients receiving opioid treatment by highlighting the dangers of combining certain medications.

Plain English
This study looked at people in Scotland who were receiving treatment for opioid addiction to see how their treatment affected their risk of getting tested for COVID-19, testing positive, or being hospitalized or dying from the disease. Out of over 36,000 individuals studied, just over 19,000 were tested for COVID-19, with 8.3% testing positive and 1.5% either hospitalized or dying. The results showed that recent treatment made it less likely to test positive for COVID-19, but if they did test positive, those on recent treatment were more than twice as likely to be hospitalized or die from the illness. Who this helps: This research helps patients in opioid treatment and healthcare providers by highlighting the need for increased vaccination and care strategies.

Plain English
This study examined a digital system that combines a wearable sensor and a smartphone app to provide vestibular physical therapy for people with multiple sclerosis (MS). Researchers found that 12 out of 16 participants used the system, achieving a 60% adherence rate to their exercise program. They reported significant improvements in balance and reduction in dizziness, such as a 2.25-point increase on a balance test and a 23 beats per minute drop in dizziness intensity during head movements. Who this helps: Patients with multiple sclerosis can benefit from this technology, making therapy more accessible and effective.

Plain English
This study looked at eight patients diagnosed with a specific type of frontotemporal dementia known as right temporal variant FTD. Researchers found that these patients showed significant loss of brain tissue in areas related to memory and language, particularly on the right side, and experienced symptoms like lack of motivation, withdrawal from social activities, and difficulty recognizing people. These findings are important because they help clarify how this type of dementia differs from other conditions, which can lead to better diagnosis and treatment. Who this helps: This helps doctors and caregivers better understand and support patients with right temporal variant FTD.

Plain English
This study looked at how different ways of involving participants in research on digital health technologies—like apps and wearables—affect their commitment to the studies. Researchers found that, on average, 77.2% of participants stayed in the studies, with over 80% remaining engaged in the first month. However, participants facing serious illnesses or new mothers had the lowest engagement, highlighting the need for more tailored support for these groups. Who this helps: This helps patients, especially those with severe health conditions and new mothers, by improving their experience with health research.

Plain English
This study looked at how cardiovascular risk factors and genetics might affect brain functioning and cognitive abilities in middle-aged people who are otherwise healthy. Researchers found that higher cardiovascular risk scores linked to poorer cognitive performance and that a key brain connection weakened over two years. These findings matter because they indicate that addressing cardiovascular health in midlife could help preserve brain function and potentially delay the onset of dementia. Who this helps: This helps patients and healthcare providers by highlighting the importance of managing cardiovascular health to protect against dementia.

Plain English
This study looked at how being male or female, along with lifestyle activities, affects brain health in middle-aged adults who may be at higher risk for Alzheimer's disease due to genetics. Researchers found that women had better memory skills but lower job achievement than men, and engaging in stimulating activities helped improve memory for everyone, regardless of gender. Notably, women who had better jobs performed better on memory tests, while this link was the opposite for men with the same genetic risk. Who this helps: This research benefits middle-aged adults at risk of Alzheimer's, particularly women.